Shares of MicroStrategy Inc. (NASDAQ:MSTR) have been assigned an average recommendation of “Buy” from the seven analysts that are presently covering the firm. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $213.50.
Several research firms have recently issued reports on MSTR. Mizuho upped their price objective on shares of MicroStrategy from $190.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 16th. Zacks Investment Research downgraded shares of MicroStrategy from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 3rd.
MicroStrategy (NASDAQ:MSTR) opened at 197.85 on Tuesday. The stock has a 50 day moving average of $184.73 and a 200 day moving average of $178.26. The stock has a market cap of $2.26 billion, a P/E ratio of 23.05 and a beta of 1.22. MicroStrategy has a 12-month low of $141.01 and a 12-month high of $199.70.
MicroStrategy (NASDAQ:MSTR) last posted its quarterly earnings data on Thursday, October 27th. The company reported $2.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.67 by $0.64. MicroStrategy had a net margin of 19.18% and a return on equity of 20.47%. The firm had revenue of $129.90 million for the quarter, compared to the consensus estimate of $126.77 million. During the same quarter in the prior year, the company posted $2.06 earnings per share. The company’s revenue for the quarter was up .3% compared to the same quarter last year. On average, equities research analysts anticipate that MicroStrategy will post $7.69 earnings per share for the current fiscal year.
In other news, Director Jarrod M. Patten sold 3,317 shares of the firm’s stock in a transaction that occurred on Friday, November 18th. The shares were sold at an average price of $197.20, for a total transaction of $654,112.40. Following the sale, the director now owns 3,317 shares of the company’s stock, valued at approximately $654,112.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 20.19% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its stake in shares of MicroStrategy by 30.3% in the third quarter. Price T Rowe Associates Inc. MD now owns 4,736 shares of the company’s stock worth $793,000 after buying an additional 1,100 shares during the last quarter. Verition Fund Management LLC purchased a new stake in shares of MicroStrategy during the third quarter worth approximately $201,000. Panagora Asset Management Inc. boosted its stake in shares of MicroStrategy by 615.8% in the third quarter. Panagora Asset Management Inc. now owns 4,703 shares of the company’s stock worth $787,000 after buying an additional 4,046 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in shares of MicroStrategy during the third quarter worth approximately $1,075,000. Finally, Perkins Investment Management LLC boosted its stake in shares of MicroStrategy by 119.9% in the third quarter. Perkins Investment Management LLC now owns 93,668 shares of the company’s stock worth $15,684,000 after buying an additional 51,074 shares during the last quarter. 85.97% of the stock is currently owned by institutional investors and hedge funds.